Company intelligence
Endologix LLC
Delivering Healthcare Innovation
About Endologix LLC
Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence. With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.
Verified activity
Signals from Endologix LLC
5 published signals
Research & Knowledge
Endologix LLC published a report from a retrospective independent study in the May 2026 issue of JVS-Vascular Insights demonstrating 10-year durability for the Ovation stent graft with Adaptive Sealing Technology.
Reported by Endologix LLC
Presence & Recognition
Endologix LLC employee Dr. Karthikeshwar Kasirajan delivered part 3 of his patient selection webinar detailing the technical aspects of the PTAB procedure.
Reported by Endologix LLC
Research & Knowledge
Endologix LLC published a case report in the Journal of Critical Limb Ischemia highlighting the utility of the DETOUR System in a PAD patient with CLI and single-vessel runoff.
Reported by Endologix LLC
Research & Knowledge
Endologix LLC published a retrospective study of the Ovation stent graft with Adaptive Sealing Technology demonstrating long-term outcomes of durable abdominal aortic aneurysm exclusion through extended follow-up with a mean of 83 months.
Reported by Endologix LLC
Presence & Recognition
Endologix LLC partnered with the Global PAD Association to raise awareness for Peripheral Artery Disease by walking toward a goal of 60k miles
Reported by Endologix LLC